Trial Court Rules In Favor of Novel Labs. Invalidating Three Patents and Federal Circuit Summarily Affirms

Represented Novel Laboratories, Inc., a pharmaceutical company seeking to market a generic version of Intermezzo®. Intermezzo® is a sublingual formulation of zolpidem indicated for middle-of-the-night insomnia. Following a 10-day bench trial, Chief Judge Linares found in favor of our client, ruling that the asserted claims of all three patents-in-suit were invalid as obvious. The Federal Circuit confirmed the invalidity findings in a summary affirmance. LMG Life Sciences named this case one of the Hatch-Waxman Impact Cases of the Year in 2016. Purdue Pharm. v. Actavis Elizabeth LLC, 15-1659 (Fed. Cir.); Purdue Pharm. Products LP v. Actavis Elizabeth LLC, 12-5311 (D.N.J.).

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.
Disclaimer

Related Practices

Hatch-Waxman Litigation Intellectual Property and Technology Litigation

Similar Results

$89 Million in Grantley v. Clear Channel Communications, Inc.
Intellectual Property and Technology Litigation Software Litigation Attorney
Advanced Micro Devices v. Samsung
Business Litigation Intellectual Property and Technology Litigation Patent Litigation
Defended Amneal in Hatch-Waxman Litigation Involving Generic Pulmonary Fibrosis Drug
Intellectual Property and Technology Litigation Patent Litigation Hatch-Waxman Litigation
Defended Chinese Pharma Co. and CEO of NJ-Based Pharma Co., Successfully Settling Shareholder Derivative Case Alleging Trade Secret Misappropriation
Business Litigation Intellectual Property and Technology Litigation Trade Secret Litigation
Obtained Complete Dismissal with Prejudice of All Claims Asserted against Medical Device Companies for Patents Covering Pulse Electromagnetic Field (PEMF) Technology
Intellectual Property and Technology Litigation Patent Litigation
Successfully Dismissed All Claims Against Medtronic in Case Involving Patent Inventorship, Unjust Enrichment, and Allegations of Trade Secret Misappropriation
Intellectual Property and Technology Litigation Patent Litigation Trade Secret Litigation
Collegium Pharmaceutical Inc. v. Teva Pharmaceuticals USA
Hatch-Waxman Litigation
Defended Upsher-Smith in Hatch-Waxman Litigation Involving Isotretinoin Capsules
Intellectual Property and Technology Litigation Hatch-Waxman Litigation Patent Litigation
Greenthread, LLC v. Samsung Electronics Co., Ltd. et al.
Intellectual Property and Technology Litigation Patent Litigation
Defended Mailchimp and Obtained Dismissal of Patent Litigation Involving Email Content Creation Technology
Intellectual Property and Technology Litigation Patent Litigation
Obtained Freedom to Operate for Sherwin-Williams through Successful Defense of Patent Infringement Case Involving Antimicrobial Chemicals
Intellectual Property and Technology Litigation Patent Litigation Patent Office Trials
Secured Judgment in Excess of $2 Million for Covidien Against a Former Employee Who Used Confidential Information to Start His Own Company
Intellectual Property and Technology Litigation Trade Secret Litigation
Represented Zenara Pharma in Litigation over Cerdelga
Hatch-Waxman Litigation Intellectual Property and Technology Litigation
Obtained Favorable Result for Electronic Medical Record System Company in Assertion of Trade Secret Misappropriation against Former Customer
Intellectual Property and Technology Litigation Trade Secret Litigation
Obtained Settlement for Celgard in Patent Litigation against Targray, a Competitor in the Battery Separator Market
Intellectual Property and Technology Litigation Patent Litigation
Back to Top